drugset / Trial / NCT01671787
A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B
RandomizedParallel-groupOpen-labelTreatment
Summary
This is an open-label study evaluating multiple doses of GS-7340 versus Tenofovir disoproxil fumarate (TDF).
Timeline
- Start
- 2012-03
- Primary completion
- 2013-04
- Completion
- 2013-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tenofovir disoproxil fumarate | Small molecule | 300 mg | — |
| Subject | tenofovir alafenamide | Small molecule | 8 mg | — |
| Subject | tenofovir alafenamide | Small molecule | 25 mg | — |
| Subject | tenofovir alafenamide | Small molecule | 40 mg | — |
| Subject | tenofovir alafenamide | Small molecule | 120 mg | — |